File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/ehf2.13014
- Scopus: eid_2-s2.0-85091269838
- PMID: 32964655
- WOS: WOS:000571784400001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
Title | The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction |
---|---|
Authors | |
Keywords | Heart failure with preserved ejection fraction Tricuspid regurgitation Predictors Prognosis |
Issue Date | 2020 |
Publisher | Wiley for the Heart Failure Association of the European Society of Cardiology. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2055-5822 |
Citation | ESC Heart Failure, 2020, v. 7 n. 6, p. 4051-4060 How to Cite? |
Abstract | Aims:
Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with stage C HF with preserved ejection fraction (HFpEF). We aimed to investigate the prevalence and prognosis of TR in patients with HFpEF.
Methods and results:
From 2013 to 2017, 2014 patients with stage B (n = 1341) or C (n = 673) HFpEF were enrolled in the study. Detailed transthoracic echocardiogram was performed, and the severity of TR was graded as no, mild, moderate, and severe. The mean age of the study population was 66.7 ± 14.1 years old, and 46% were men. Mean left ventricular ejection fraction was 62.2 ± 5.5%. The prevalence of moderate/severe TR increased from stage B to C HF (8% to 16%, respectively, P < 0.01). Older age, hyperlipidaemia, atrial fibrillation, left ventricular mass, and right ventricular systolic pressure were independently associated with moderate/severe TR (P < 0.05 for all). With a median follow-up of 3.8 (2.9–4.7) years, 346 patients died and 234 developed HF requiring hospitalization. Kaplan–Meier curve revealed that the presence of moderate/severe TR was associated with all-cause mortality, HF requiring hospitalization and cardiovascular death (log-rank test P < 0.01). Multivariable analysis demonstrated that moderate (hazard ratio = 1.5; 95% confidence interval: 1.1–2.2; P < 0.05) and severe TR (hazard ratio = 2.1; 95% confidence interval: 1.3–3.3; P < 0.01) were independently associated with mortality, HF requiring hospitalization and cardiovascular death.
Conclusions:
The presence of moderate/severe TR is not uncommon in patients with stage B HF and stage C HFpEF. Importantly, moderate/severe TR was independently associated with mortality and HF requiring hospitalization. |
Persistent Identifier | http://hdl.handle.net/10722/293815 |
ISSN | 2023 Impact Factor: 3.2 2023 SCImago Journal Rankings: 1.425 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ren, QW | - |
dc.contributor.author | Li, XL | - |
dc.contributor.author | Fang, J | - |
dc.contributor.author | Chen, Y | - |
dc.contributor.author | WU, MZ | - |
dc.contributor.author | YU, YJ | - |
dc.contributor.author | Liao, SG | - |
dc.contributor.author | Tse, HF | - |
dc.contributor.author | Yiu, KH | - |
dc.date.accessioned | 2020-11-23T08:22:11Z | - |
dc.date.available | 2020-11-23T08:22:11Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | ESC Heart Failure, 2020, v. 7 n. 6, p. 4051-4060 | - |
dc.identifier.issn | 2055-5822 | - |
dc.identifier.uri | http://hdl.handle.net/10722/293815 | - |
dc.description.abstract | Aims: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with stage C HF with preserved ejection fraction (HFpEF). We aimed to investigate the prevalence and prognosis of TR in patients with HFpEF. Methods and results: From 2013 to 2017, 2014 patients with stage B (n = 1341) or C (n = 673) HFpEF were enrolled in the study. Detailed transthoracic echocardiogram was performed, and the severity of TR was graded as no, mild, moderate, and severe. The mean age of the study population was 66.7 ± 14.1 years old, and 46% were men. Mean left ventricular ejection fraction was 62.2 ± 5.5%. The prevalence of moderate/severe TR increased from stage B to C HF (8% to 16%, respectively, P < 0.01). Older age, hyperlipidaemia, atrial fibrillation, left ventricular mass, and right ventricular systolic pressure were independently associated with moderate/severe TR (P < 0.05 for all). With a median follow-up of 3.8 (2.9–4.7) years, 346 patients died and 234 developed HF requiring hospitalization. Kaplan–Meier curve revealed that the presence of moderate/severe TR was associated with all-cause mortality, HF requiring hospitalization and cardiovascular death (log-rank test P < 0.01). Multivariable analysis demonstrated that moderate (hazard ratio = 1.5; 95% confidence interval: 1.1–2.2; P < 0.05) and severe TR (hazard ratio = 2.1; 95% confidence interval: 1.3–3.3; P < 0.01) were independently associated with mortality, HF requiring hospitalization and cardiovascular death. Conclusions: The presence of moderate/severe TR is not uncommon in patients with stage B HF and stage C HFpEF. Importantly, moderate/severe TR was independently associated with mortality and HF requiring hospitalization. | - |
dc.language | eng | - |
dc.publisher | Wiley for the Heart Failure Association of the European Society of Cardiology. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2055-5822 | - |
dc.relation.ispartof | ESC Heart Failure | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Heart failure with preserved ejection fraction | - |
dc.subject | Tricuspid regurgitation | - |
dc.subject | Predictors | - |
dc.subject | Prognosis | - |
dc.title | The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction | - |
dc.type | Article | - |
dc.identifier.email | Tse, HF: hftse@hkucc.hku.hk | - |
dc.identifier.email | Yiu, KH: khkyiu@hku.hk | - |
dc.identifier.authority | Tse, HF=rp00428 | - |
dc.identifier.authority | Yiu, KH=rp01490 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1002/ehf2.13014 | - |
dc.identifier.pmid | 32964655 | - |
dc.identifier.pmcid | PMC7754967 | - |
dc.identifier.scopus | eid_2-s2.0-85091269838 | - |
dc.identifier.hkuros | 319713 | - |
dc.identifier.volume | 7 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 4051 | - |
dc.identifier.epage | 4060 | - |
dc.identifier.isi | WOS:000571784400001 | - |
dc.publisher.place | United Kingdom | - |